EU CER for Medical Devices

EU Clinical Evaluation Requirements

Under the European Union Medical Device Regulation (EU MDR 2017/745), clinical evaluation has evolved from a periodic task into a continuous lifecycle obligation. A Clinical Evaluation Report (CER) is a mandatory component of the Technical Documentation for all medical devices, regardless of their risk classification. It serves as the definitive record of the systematic process used to collect, appraise, and analyze clinical data to verify the general safety and performance requirements (GSPR) of a device.

As the EU regulatory framework prioritizes patient safety and clinical benefit, manufacturers must demonstrate a proactive approach to evidence generation. The CER must substantiate that the device achieves its intended purpose during normal use and that any associated risks are outweighed by the clinical benefits. This requires a rigorous integration of pre-market clinical investigations and post-market clinical data, ensuring the benefit-risk profile remains favorable throughout the product's entire market life.

Fundamental Components of a Compliant CER

A robust CER must be structured to meet the high evidence thresholds set by the MDR and aligned with MEDDEV 2.7/1 Rev. 4 guidelines. The document must be self-sufficient and capable of withstanding intensive scrutiny from Notified Bodies during the conformity assessment process.

Technical device description and intended purpose

The report begins with a detailed description of the device's physical and technical characteristics, clearly defining its intended use, target population, and medical indications. Any specific claims regarding therapeutic or diagnostic outcomes must be explicitly stated and supported by the subsequent clinical evidence.

State of the art and clinical background

Manufacturers must document the current "State of the Art" (SOTA) in the relevant medical field. This involves identifying alternative treatments, their respective benefits and risks, and the benchmark standards for the clinical condition being addressed. This context allows regulators to evaluate the device's performance relative to existing medical practices and ensures the technology remains relevant in a changing clinical landscape.

Clinical data identification and appraisal

The CER must include a systematic literature review (SLR) that covers clinical data related to the device under evaluation or a proven equivalent device. The appraisal process involves weighing data based on its scientific quality and relevance, ensuring that only valid clinical evidence supports the final conclusions regarding safety and performance.

Lifecycle Management and Continuous Updates

A CER is not a static document but a "living" file that requires regular maintenance. The frequency of updates depends on the risk classification of the device and the availability of new clinical information. For high-risk or innovative devices, annual updates are often required, whereas for well-established, low-risk devices, the update cycle may be extended to every two to five years.

Continuous updates are driven by the integration of Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) data. Whenever new information arises from vigilance reporting or field safety corrective actions that could alter the current evaluation, the CER must be revised immediately to reflect the updated benefit-risk assessment. This ensures that the device's technical file always reflects its real-world performance.

Proregulations' EU MDR Clinical Evaluation Services

Our standardized service process facilitates the efficient navigation of the EU MDR clinical evaluation pathway for various medical device portfolios. We offer a comprehensive suite of solutions to manage every stage of the CER lifecycle.

• Clinical evaluation planning and scoping
  We assist in developing a Clinical Evaluation Plan (CEP) that defines the objectives, methodology, and acceptance criteria for your clinical evidence.
• Systematic literature search and review
  Our team performs exhaustive literature reviews using clinical databases to gather and appraise data for the device or its equivalents.
• CER drafting and technical alignment
  We compile and draft the CER in full compliance with MDR Article 61, ensuring seamless integration with risk management and PMS documentation.
• Clinical data gap analysis
  We identify potential weaknesses in your clinical evidence base and provide strategic recommendations for PMCF or clinical investigation activities.
• Notified Body audit support
  We provide technical advocacy during Notified Body reviews, assisting with responses to exigencies and ensuring your documentation meets evaluator expectations.
• Legacy device transition support
  We help manufacturers transition their existing MDD-compliant CERs to meet the more rigorous evidence requirements of the EU MDR.

If you are interested in our EU CER compliance services and wish to ensure your clinical documentation meets the highest regulatory standards, please feel free to contact us.